Zymtronix develops a patented platform technology that allows innovative and efficient enzyme processes.
Zymtronix develops technology for enzyme immobilization. It provides a platform to immobilize enzymes and screen for immobilized enzyme performance, the unlocked potential of oxidative enzymes for biocatalysis, and new materials and customer-oriented processes for small molecule conversion. The company is optimizing enzyme immobilization to create unique, and sustainable and responsible processes for high-performance biocatalysis. Stéphane Corgié founded Zymtronix in 2013. It has its headquarters in Ithaca in New York.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 2, 2015 | Grant | $1.08M | 1 |
National Science Foundation
|
— | Detail |
| Nov 13, 2013 | Grant | $179.99K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |